ArticleCancer cell2015

Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.

Shuo-Chieh Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.